Advanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC
17 oct. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
Advanced Accelerator Applications Announces Presentations on Lutathera® NETTER-1 Phase III and NeoBOMB1 at EANM
11 oct. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications Announces Revised EMA Review Timeline for Lutathera®
20 sept. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC Kit for Radiopharmaceutical Preparation of Gallium (Ga 68) Edotreotide for Gastroenteropancreatic Neuroendocrine Tumor Detection
16 sept. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Sept. 16, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
Advanced Accelerator Applications Reports 24.4% Sales Growth in the Second Quarter of 2016
31 août 2016 07h00 HE
|
Advanced Accelerator Applications
Highlights: Sales for the second quarter of 2016 increased 24.4% compared to the second quarter of 2015The U.S. Food and Drug Administration (FDA) granted Priority Review for Lutathera, with a...
Advanced Accelerator Applications Announces Opening of First U.S. Manufacturing Facility; Preparation for Anticipated Lutathera Launch
26 juil. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, July 26, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications Provides Lutathera Update
23 mars 2016 07h00 HE
|
Advanced Accelerator Applications
Lutathera Expanded Access Program Now Open In U.S. to Eligible Patients NDA Filing to FDA and EMA Forthcoming SAINT-GENIS-POUILLY, France, March 23, 2016 (GLOBE NEWSWIRE) -- Advanced...